NCT03205137撤回不适用
Comparison of the Medication Adherence of Patients Treated With Telmisartan/Hydrochlorothiazide or Telmisartan/Amlodipine Fixed Dose Combination (FDC) Versus Double-pill Combination Therapy Based on Database Data in Real-world Japanese Therapeutic Practice
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Proportion of days covered of patients treated with single- and double- combination therapy
研究概览
简要总结
The primary objective of this study is to compare the medication adherence measured by PDC of patients with FDC or double-pill combination therapy in real-world Japanese therapeutic practice.The further objective of this study is how much influence the background of patients to the adherence.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 40 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with hypertension
- •Patients must have their first prescription (defined as index date*) for telmisartan and hydrochlorothiazide or Micombi® between 01/07/2010 and 28/09/2010
- •Patients must have their first prescription (defined as index date*) for telmisartan and amlodipine or Micamlo® between 10/12/2010 and 09/03/2011
- •Patients must have at least 180 days follow up verified by the presence of prescription record
排除标准
- •Patients who were under 40 years old at the time of enrolment
- •Patients who prescribed the study drugs less than 90 days during a follow up period of 180 days
- •Patients whose visits are less than 2 times during a follow up period of 180 days
研究组 & 干预措施
Telmisartan and hydrochlorothiazide group
干预措施: subjects treated with telmisartan/hydrochlorothiazide (Drug)
Telmisartan and amlodipine group
干预措施: Subjects treated with Telmisartan and amlodipine (Drug)
Telmisartan+hydrochlorothiazide double-pill combination group
干预措施: subjects treated with Telmisartan+hydrochlorothiazide double-pill combination group (Drug)
telmisartan+amlodipine double-pill combination group
干预措施: subjects treated with telmisartan+amlodipine double pill (Drug)
结局指标
主要结局
Proportion of days covered of patients treated with single- and double- combination therapy
时间窗: 180 days
次要结局
- Demographic and clinical characteristics of patients treated with single- and double combination(180 days)
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
3 期
Incidence of Non Adherence to Treatment With Once-daily Formulation of TacrolimusMedication AdherenceNCT02805842Rabin Medical Center60
已完成
不适用
Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and ComorbiditiesHIV Infection PrimaryNCT03387397Northwell Health170
已完成
不适用
Pharmacist-Led Intervention to Improve TB Treatment AdherenceTuberculosis, PulmonaryHIV CoinfectionNCT06608069Universiti Sains Malaysia383
终止
不适用
Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)Chronic Recurrent Multifocal OsteomyelitisNCT06232603Seattle Children's Hospital9
已完成
不适用
Comparative Analysis of Adherence and Effectiveness Outcomes Between Rheumatoid Arthritis (RA) Patients Treated With Tofacitinib Modified Release (MR)Rheumatoid ArthritisNCT04018001Pfizer1,057